Studies on the epidemiology of nontuberculous mycobacteriosis in Japan

The American Review of Respiratory Disease
M TsukamuraA Kuze

Abstract

The epidemiology of mycobacterial disease in Japan changed considerably over the period 1971 to 1984. During this time, the incidence of pulmonary disease caused by Mycobacterium tuberculosis has steadily declined; disease caused by M. avium complex has remained stable; disease caused by M. kansasii has increased considerably; and, for the first time, substantial numbers of cases caused by M. szulgai, M. fortuitum, M. chelonae, and M. nonchromogenicum have been reported. From 1981 to 1984 the incidence of pulmonary nontuberculous mycobacterioses (NTM) was estimated at 1.73 +/- 0.25 cases per 100,000 population per year; of these, M. avium complex constituted 1.29 +/- 0.24 and M. kansasii 0.34 +/- 0.11 per 100,000 per year. The prevalence of the NTM was relatively high in southwestern Japan (industrialized, warm climate) and low in northern Japan (rural, cold).

Citations

Jun 1, 2010·The Indian Journal of Surgery·Amit Kumar ShahR Katoch
Feb 22, 2001·Archivos de bronconeumología·J Garrós GarayE Ruiz de Gordejuela
May 3, 2000·The British Journal of Dermatology·T ShimizuS Taniguchi
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D P O'BrienV L Krause
Jun 1, 1997·The American Journal of the Medical Sciences·D A BenatorF M Gordin
Aug 1, 1994·Acta Paediatrica Japonica; Overseas Edition·J NishiK Miyata
May 18, 2007·American Journal of Respiratory and Critical Care Medicine·Kamran KhanTheodore K Marras
Dec 15, 2007·American Journal of Respiratory and Critical Care Medicine·Seigo KitadaUNKNOWN MAC Serodiagnosis Study Group
May 5, 2012·PloS One·Chang-Chieh ChenHsin-Chih Lai
Mar 2, 2006·Internal Medicine·Yong Soo KwonByung-Tae Kim
Feb 6, 2009·Emerging Infectious Diseases·Patricia C A M BuijtelsDick van-Soolingen
Mar 12, 2011·Emerging Infectious Diseases·Sami SimonsDick van Soolingen
Sep 6, 2011·Emerging Infectious Diseases·Kevin L WinthropKatrina Hedberg
Nov 21, 2008·Journal of Clinical Laboratory Analysis·Sung Weon RyooSeongman Kang
Aug 2, 2011·The Clinical Respiratory Journal·Ginevra Del GiudiceCarlo Marzo
Feb 1, 1996·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·L B Heifets
Oct 10, 2002·Clinics in Chest Medicine·Theodore K Marras, Charles L Daley
Dec 24, 2013·Scandinavian Journal of Infectious Diseases·Hongseok YooWon-Jung Koh
Aug 16, 2001·The Journal of Veterinary Medical Science·A IwakiriY Goto
Jan 13, 2015·BMC Infectious Diseases·Junghyun KimJae-Joon Yim
Aug 19, 2014·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Xiuqin ZhaoYu Pang
May 27, 2009·Respiratory Medicine·Chun-Ta HuangUNKNOWN Tami Group
Oct 17, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P C A M BuijtelsD van Soolingen
Jan 14, 2017·Zoonoses and Public Health·S ThirunavukkarasuR J Whittington
May 15, 2007·ANZ Journal of Surgery·Elizabeth JacksonRobert E Norton
Dec 20, 2005·Journal of Korean Medical Science·Jae-Joon YimYoung-Soo Shim
May 26, 2010·Yonsei Medical Journal·Hye Kyeong ParkO Jung Kwon
Sep 25, 2002·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Won-Jung KohKyung Soo Lee
Nov 21, 2017·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Sovetzhan Z BasybekovNazym S Syrym

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.